Abstract
We hypothesized that, by inhibiting myocardial late Na+ current, Ranolazine improves angina symptoms, exercise tolerance and coronary microvascular function in patients with microvascular ischemia. In this pilot randomized, double-blinded, placebo-controlled trial, 24 patients with angina symptoms
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
